Mobilization of peripheral blood stem cells in patients with advanced thoracic malignancies after irinotecan (CPT-11) administration. [electronic resource]
Producer: 19980513Description: 481-7 p. digitalISSN:- 0250-7005
- ADP-ribosyl Cyclase
- ADP-ribosyl Cyclase 1
- Aged
- Antigens, CD
- Antigens, CD34
- Antigens, Differentiation
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Blood Cell Count
- Camptothecin -- adverse effects
- Colony-Forming Units Assay
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cells
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Membrane Glycoproteins
- Mesothelioma -- drug therapy
- Middle Aged
- NAD+ Nucleosidase
- Neutropenia -- chemically induced
- Topoisomerase I Inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.